Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
0.00%
)
US TECH 100
22,812.00
(
-0.61%
)
Dow Jones
45,960.11
(
0.00%
)
Brent Oil
104.38
(
3.69%
)
Bitcoin
66,585.00
(
-3.20%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122815
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: RockRat post# 101577

Friday, 08/13/2010 4:27:18 PM

Friday, August 13, 2010 4:27:18 PM

Post# of 257295

…the Bernstein analyst is going to look stupid calling for Teva's version to be approved before year end.

Does he care about looking stupid, or does he care about making money for Bernstein clients (and/or the firm itself)? From Bernstein’s behavior in January (#msg-45811783), I suspect the answer is the latter.

p.s. The bogus Bernstein report in January caused MNTA’s share price to reach $16.45 on 1/22/10, which is higher than where it closed today. The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today